IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms’ Tumor via MAPK Signaling Pathway

<div>Bioinformatics analysis of infiltrating immune cells and stromal cells in WT samples. Compared the ESTIMATE algorithm results of immune cells, stromal cells, and estimate scores in WT sample and adjacent kidney sample by Wilcoxon test, respectively (a). Compared the immune scores of WT sample with the adult ccRCC (b). Kaplan-Meier survival analysis of the prognosis between high and low immune scores group (c).</div>

Journal of Oncology

fig1

Figure 1

Figure 1: IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms’ Tumor via MAPK Signaling Pathway 

Figure 1 | IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms’ Tumor via MAPK Signaling Pathway 